Gallbladder cancer staging with 18F-FDG PET-CT;Estadificación del cáncer de vesícula mediante tomografía de positrones con 18F-fluorodesoxiglucosa

Revista Espanola de Medicina Nuclear

Volumn 28, Issue 2, 2009, Pages 74-77

  Ramos Font, C ^a   Santiago Chinchilla, A ^a   Rodriguez Fernandez A ^a   Rebollo Aguirre, Á C ^a   Gomez Rio M ^a   Llamas Elvira, J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Gallbladder cancer; PET CT; Positron emission tomography; Staging 18F Fluorodeoxyglucose

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHOLANGIOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DELAYED DIAGNOSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; FEMALE; GALLBLADDER CANCER; HUMAN; MALE; PROGNOSIS;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHOLECYSTECTOMY; CHOLELITHIASIS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GALLBLADDER NEOPLASMS; HUMANS; LIVER; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS;

EID: 65449181108     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/S0212-6982(09)70701-3     Document Type: Article

References (19)

1. Randi G., Franceschi S., and La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118 (2006) 1591-1602
2. Chao T., and Greager J.A. Primary carcinoma of the gallbladder. J Surg Oncol 46 (1991) 215-221
3. Cleary S.P., Dawson L.A., Knox J.J., and Gallinger S. Cancer of the gallbladder and extrahepatic bile ducts. Curr Probl Surg 44 (2007) 396-482
4. Reid K.M., Ramos de la Medina A., and Donohue A. Diagnosis and surgical management of gallbladder cancer: a Review. J Gastrointestinal Surg 11 (2007) 671-681
5. Miller G., Schwartz L.H., and D'Angelica M. The use of imaging in the diagnosis and staging of hepatobiliary malignancies. Surg Oncol Clin N Am 16 (2007) 343-368
6. Rodríguez-Fernández A., Gómez-Río M., Medina-Benítez A., Moral J.V., Ramos-Font C., Ramia-Angel J.M., et al. Application of modern imaging methods in diagnosis of gallbladder cancer. J Surg Oncol 93 (2006) 650-664
7. Lomis K.D., Vitola J.V., Delbeke D., Snodgrass S.L., Chapman W.C., Wright J.K., et al. Recurrent gallbladder carcinoma at laparoscopy port sites diagnosed by positron emission tomography: implications for primary and radical second operations. Am Surg 63 (1997) 341-345
8. Cózar M.P., Ortega F., Fuster C., Vázquez-Albadalejo C., Santos J., and Almenar S. Detección por PET de una tumoración primaria de vesícula biliar y adenopatía metastásica pericística. Rev Esp Med Nucl 25 (2006) 113-114
9. Koh T., Taniguchi H., Yamaguchi A., Kunishima S., and Yamagishi H. Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET). J Surg Oncol 84 (2003) 74-81
10. Anderson C.D., Rice M.H., Pinson C.W., Chapman W.C., Chari R.S., and Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8 (2004) 90-97
11. Rodríguez-Fernández A., Gómez-Río M., Llamas-Elvira J.M., Ortega-Lozano S., Ferrón-Orihuela J.A., Ramia-Angel J.M., et al. Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosis. Am J Surg 188 (2004) 171-175
12. Wakabayashi H., Akamoto S., Yachida S., Okano K., Izuishi K., Nishiyama Y., et al. Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture. Eur J Surg Oncol 31 (2005) 1175-1179
13. Oe A., Kawabe J., Torii K., Kawamura E., Higashiyama S., Kotani J., et al. Distinguishing benign from malignant gallbladder wall thickening using FDG-PET. Ann Nucl Med 20 (2006) 699-703
14. Corvera C.U., Blumgart L.H., Akhurst T., DeMatteo R.P., D'Angelica M., Fong Y., et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 206 (2008) 57-65
15. Petrowsky H., Wildbrett P., Husarik D.B., Hany T.F., Tam S., Jochum W., et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 45 (2006) 43-50
16. Núñez R., Yeung H.W., Swanston N.M., and Macapinlac H.A. Captación de fluordesoxiglucosa en la vesicular biliar en la PET y la PET-TAC de tres pacientes oncológicos. Rev Esp Med Nucl 26 (2007) 234-236
17. Ramia J.M., Muffak K., Rodríguez-Fernández A., Villar J., Garrote D., and Ferron J.A. Gallbladder tuberculosis: false-positive PET diagnosis of gallbladder cancer. World J Gastroenterol 12 (2006) 6559-6560
18. Kitazono M.T., and Colletti P.M. FDG PET imaging of acute cholecystitis. Clin Nucl Med 31 (2006) 23-24
19. Maldjian P.D., Ghesani N., Ahmed S., and Liu Y. Adenomyomatosis of the gallbladder: another cause for a "hot" gallbladder on 18F-FDG PET. AJR Am J Roentgenol 189 (2007) W36-W38